YPB gains second early adopter of its key MotifMicro technology

|

Published 02-DEC-2019 12:31 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Product authentication and consumer engagement solutions provider YPB Group Limited (ASX:YPB) today announced it has signed a second early adopter of its high security, smartphone readable, authentication technology MotifMicro.

OPP Gravure Printing Co Ltd has signed a six month early adopter agreement to explore product innovation and the commercialisation of MotifMicro with its customer base in Thailand and South-East Asia. This initial six month contract has to potential upgrade to a three year licence term.

OPP Gravure is a leading printer in Thailand with a range of domestic and multi-national consumer brands producers, such as Kelloggs as customers, and with specialisation in industries such as food packaging, pharma, personal care products and vehicle spare parts.

This agreement contemplates a further three year licence agreement at the end of the adopter term or at OPP’s request, including an upfront licence fee, supply fee on a per unit basis and a minimum order quantity.

The contract is expected to produce revenue in the first quarter of 2020 from the six month early adopter agreement with customers charged on a per unit basis, leveraging contract revenues to OPP’s client’s production volumes of around 250 million items per annum. However, at this stage it is too early to predict revenues.

OPP’s particular expertise is in PVC products and shrink wrap with its output applied to approximately 250m units of its customers’ production per annum. YPB’s recent creation of a high security, smartphone readable shrink wrap was in collaboration with OPP at its Bangkok plant. MotifMicro was successfully incorporated into a shrink-wrap production line under high volume production line conditions.

YPB believes this to be the world’s first high security, smartphone readable PVC shrink-wrap product of its kind. This early adopter program with OPP follows the September 2019 agreement with China’s leading security label producer, PanPass Inc, as the first early adopter of MotifMicro, and the certification of MotifMicro as meeting FDA food contact specifications by Switzerland’s SGS.

YPB Group CEO, John Houston, said: “This second partnership so soon after MotifMicro’s successful achievement of high functionality under “real world” conditions reflects the uniqueness and commercial potential of MotifMicro. It also strengthens our route to market in Thailand and SE Asia with a capable, innovative and widely respected partner.”

tags

TECH


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X